SRL
IBRX icon

Scientech Research LLC’s ImmunityBio IBRX Stock Holding History

Scientech Research LLC’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$131K Sell
15,008
-10,760
-42% -$81.4K 0.11% 170
2026
Q1 		$198K Buy
+25,768
New +$176K 0.16% 252

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Scientech Research LLC's IBRX Position: Q2 2026 in Review

Scientech Research LLC reduced its ImmunityBio (IBRX) stake by 42% in Q2 2026, selling an estimated $81.4K and leaving 15,008 shares worth $131K. The position accounts for 0.11% of the portfolio, ranked #170.

Scientech Research LLC first reported a position in IBRX in Q1 2026 and has held it in 2 quarters since. The position peaked at $198K in Q1 2026. 404 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Scientech Research LLC held 15,008 shares of ImmunityBio worth $131K as of Q2 2026.
  • Scientech Research LLC sold 10,760 ImmunityBio shares in Q2 2026, an estimated $81.4K.
  • ImmunityBio made up 0.11% of Scientech Research LLC's portfolio in Q2 2026, its #170 holding.
  • Scientech Research LLC first reported a position in ImmunityBio in Q1 2026 and has held it in 2 quarters since.
  • Scientech Research LLC's ImmunityBio position peaked at $198K in Q1 2026.
  • 404 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.